0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Hypothalamic versus Pituitary Stimulation of Luteinizing Hormone Secretion in the Prepubertal Female Lamb

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Glutamate and aspartate have been hypothesized to function as neurotransmitters in the regulation of the gonadotropin-releasing hormone (GnRH) neurosecretory system. We, therefore, determined if hypothalamic stimulation of luteinizing hormone (LH) secretion in the intact prepubertal female lamb could be achieved by intravenous injection of N-methyl-D,L-aspartate (NMA), a glutamate agonist. A pilot study determined a dose of NMA that would induce physiologic pulses of LH (GnRH). Subsequently, we compared the ability of NMA with exogenous GnRH to induce ovulation in the prepubertal lamb when administered chronically. Eighteen prepubertal lambs (21 weeks of age, 34.2 ± 1.5 kg body weight) were treated intravenously with either NMA (2 mg/kg, n = 6) or GnRH (68 ng/injection or approximately 2 ng/kg, n = 6) for 3 days, every 2 h on day 1 and every 1 h on days 2 and 3, or received no treatment (controls, n = 6). Gonadotropin surges were detected only in GnRH-treated lambs (5/6 lambs, onset = 54.0 ± 4.5 h from the start of study, mean ± SE). Compared to 83% of GnRH injections inducing LH pulses, only 47% of NMA injections induced LH pulses. Because each injection of NMA did not induce a pulse of LH, a second experiment was performed in an attempt to optimize the LH respone to NMA. Ten prepubertal lambs (25 weeks of age) were injected every 2 h for 24 h with higher doses of NMA, either 4 mg/kg (n = 5) or 16 mg/kg (n = 5). At the outset (first and second injections), the lower dose of NMA did not consistently induce LH pulses in all lambs; by 22 and 24 h, however, a more consistent LH response was observed. By contrast, in the high dose group, the first two and last two injections of NMA all induced LH pulses. Similar amplitudes of LH pulses were induced by the last two injections of either dose of NMA (6.3 ± 1.0 vs. 8.8 ± 2.3 ng/ml, 4 vs. 16 mg/kg, respectively); similar LH pulse amplitudes were also induced by NMA (4 and 16 mg/kg doses combined) and GnRH (2 ng/kg dose) (7.6 ± 1.2 vs. 5.7 ± 0.8 ng/ml). These results suggest that acute administration of NMA can be used to induce pulses of LH in the prepubertal lamb, and that the response appears to be ‘all-or-none’. In addition, although we were unable to sustain pulsatile LH secretion sufficiently to induce an LH surge and ovulation using a low dose of NMA (Experiment 1), a higher dose could be effective (Experiment 2, 4 mg/kg). The highest dose of NMA (16 mg/kg) was the only dose consistently able to induce LH pulses, however, adverse behavioral responses were also observed at this dose. In conclusion, glutamate/aspartate neurotransmitters may regulate the GnRH neurosecretory system in the prepubertal lamb by stimulating both inhibitory and stimulatory pathways. The dominant pathway which is activated would determine the level of reproductive activity of the lamb, with stimulatory pathways more likely to be activated during the onset of puberty.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1993
          1993
          08 April 2008
          : 57
          : 3
          : 467-475
          Affiliations
          aReproductive Sciences Program, Departments of bObstetrics and Gynecology, cBiology, dPhysiology, ePediatrics, University of Michigan, Ann Arbor, Mich. USA
          Article
          126393 Neuroendocrinology 1993;57:467–475
          10.1159/000126393
          8321419
          © 1992 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 9
          Categories
          Original Paper

          Comments

          Comment on this article